LabCompass

Yifan Sun

Medicine · Indiana University

OpenAlex ORCID
Ovarian function and disordersExtracellular vesicles in diseaseMicroRNA in disease regulationAdvanced biosensing and bioanalysis techniquesPolymer Nanocomposites and Properties

Publications

135

Citations

3,261

Est. group size

—

Recurring co-author estimate

Active years

32

Publishing since 1995

Research summary
AI-generated

The publications associated with this name span a wide range of biomedical and materials-science topics, including cancer biology and treatment (breast, liver, and other cancers), disease biomarkers found in blood (such as exosomal microRNAs in lupus nephritis), targeted drug delivery, and medical imaging techniques. Note that the listed works cover very diverse subjects—from clinical oncology to 3D-printed materials and computational physics—which may indicate that multiple different researchers share this name in the underlying data.

Cancer biology and treatmentDisease biomarkers (extracellular vesicles and microRNA)Targeted drug deliveryMedical imaging and radiologyBiosensing and diagnostic techniques

Publication activity has generally grown over the past decade, peaking around 2021-2022 and remaining active, averaging about 11 publications per year over the last five years.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 10.8/year recently
2017: 7 publications172018: 9 publications182019: 9 publications192020: 9 publications202021: 13 publications212022: 18 publications18222023: 12 publications232024: 7 publications242025: 15 publications252026: 2 publications26
Recent publications
Publishes in
  • Clinical Laboratory×6
  • Research Square×5
  • PLoS ONE×4
  • Frontiers in Bioengineering and Biotechnology×3
  • Oncotarget×3

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile